Vishnu Chemicals Q1 Revenue Grows 2.4% Amid Global Uncertainties
Vishnu Chemicals reported a 2.4% year-on-year increase in consolidated revenue to Rs 346.90 crores in Q1. Gross margins improved to 45.60%, EBITDA remained stable at Rs 55.70 crores, and PAT increased by 5.80% to Rs 32.20 crores. The company faced challenges due to tariff uncertainties affecting export markets, with a domestic-export sales mix of 55:45. The Board recommended a 15% dividend. Chromium chemicals face tariffs in the US market, while barium chemicals are exempt. The company is focusing on cost management and future growth initiatives, including strontium carbonate production and a South African mine acquisition.
05Aug 25
Vishnu Chemicals Reports 5.8% PAT Growth Amid Global Tariff Uncertainties
Vishnu Chemicals released Q1 financial results, showing resilience in challenging market conditions. Operating revenues increased by 2.4% YoY to ₹346.90 crore, while PAT grew 5.8% to ₹32.20 crore. Gross margins improved to 45.6% from 44.8%. The company faced challenges including demand deferment, increased shipping costs, and cautious customer sentiment in export markets. Domestic to exports sales mix was 55:45. Management remains optimistic about future growth despite current uncertainties.
02Aug 25
Vishnu Chemicals Reports 5.8% Growth in Q1 Consolidated Net Profit
Vishnu Chemicals Limited announced its Q1 FY2026 financial results, reporting a consolidated net profit of ₹322.24 crore, up 5.77% year-on-year. The company's income from operations rose by 2.52% to ₹3,459.46 crore, while total income increased by 2.91% to ₹3,515.48 crore. Profit before tax grew by 4.36% to ₹418.38 crore. The company's revenue is well-distributed between domestic (54.50%) and overseas (45.50%) markets. Chairman & Managing Director Ch. Krishna Murthy expressed satisfaction with the company's performance and strategic initiatives.
Vishnu Chemicals, a specialty chemicals manufacturer, posted strong Q4 results with a 40% year-over-year increase in consolidated net profit to ₹389.00 million. Revenue grew by 30% to ₹3,900.00 million. EBITDA slightly improved to ₹641.00 million, but the EBITDA margin declined to 16.31% from 21.15% in the previous year. The company demonstrated robust growth and effective cost management despite facing margin pressures in the specialty chemicals sector.